Orthofix Medical Inc

Orthofix Medical Inc(OFIX)の株式分析

$9.810

-0.177 (-1.80%)終値時点

Loading chart…
高値
9.990
始値
9.920
出来高加重平均価格
9.82
出来高
247.60K
時価総額
505.89M
安値
9.670
売買代金
2.43M
EV/EBITDA(TTM)
5.29

Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.

AI分析 of Orthofix Medical Inc (OFIX)

中立

Orthofix Medical Inc is currently a hold. The stock is priced at $9.81, with a recent RSI of 60.256 indicating it's nearing overbought territory. The forward P/E ratio is extremely high at 500, suggesting that the stock is overvalued based on future earnings expectations. Additionally, the company has seen a significant year-to-date decline of 33.89%, which raises concerns about its recovery potential. While there was a positive 5-day change of 4.58%, the overall trend remains negative, and the recent investigation into fiduciary breaches could pose further risks.

アナリスト評価(7)

上値余地 +117.43%
買い
6 買い
1 中立
0 売り
現在: 9.81
安値
18.00
平均
21.33
高値
24.00

Canaccord

2026-08-10

目標株価

$13

買い

Barrington

2026-08-06

目標株価

$14

アウトパフォーム

Stifel

2026-08-05

目標株価

$13

買い

Stifel

2026-03-09

目標株価

$18

買い

Canaccord

2026-02-26

目標株価

$20

買い

バリュエーション指標

Orthofix Medical Inc(OFIX)の現在の予想PERは500.00で、5年平均は22.49です。

予想PER

大幅な割高
5年平均 P/E
22.49
現在のP/E
500.00
割高
197.18
割安
-152.20

予想EV/EBITDA

割安
5年平均 EV/EBITDA
8.90
現在のEV/EBITDA
5.29
割高
11.71
割安
6.10

予想PSR

割安
5年平均 P/S
0.77
現在のP/S
0.46
割高
1.04
割安
0.51

Alphio AI による OFIX の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%OFIX

$10.69

シナリオ価格

基

基本

基本 · 50%OFIX

$10.56

シナリオ価格

弱

弱気

弱気 · 25%OFIX

$10.47

シナリオ価格

OFIX を保有するクジラ

P

Paradigm Capital Management, Inc.

+ を保有OFIX

-20.90%

3か月リターン

イベントタイムライン

2026-08-05 (ET)

07:30:00

Orthofix Raises 2026 Net Sales Guidance to $845-$855 Million

07:30:00

Orthofix Reports Q2 Revenue of $210.9M, Beating Expectations

2026-07-06 (ET)

09:00:00

Nasdaq and S&P 500 Futures Rise as Chip Stocks Rebound

08:00:00

Orthofix Expects Medicare Reimbursement to Return to Pre-2026 Levels

2026-05-21 (ET)

10:00:00

Stock Down $2.38 to $9.77 in Morning Trading

ニュース

OFIX のよくある質問 — Alphio AI が回答

Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Orthofix Medical Inc is currently a hold. The stock is priced at $9.81, with a recent RSI of 60.256 indicating it's nearing overbought territory. The forward P/E ratio is extremely high at 500, suggesting that the stock is overvalued based on future earnings expectations. Additionally, the company has seen a significant year-to-date decline of 33.89%, which raises concerns about its recovery potential. While there was a positive 5-day change of 4.58%, the overall trend remains negative, and the recent investigation into fiduciary breaches could pose further risks.

7 analysts cover OFIX: 6 rate it Buy, 1 Hold and 0 Sell. The average price target is 21.33.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める